Page 3 - ஹெல்த்‌க்வெஸ்ட் மூலதனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஹெல்த்‌க்வெஸ்ட் மூலதனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஹெல்த்‌க்வெஸ்ட் மூலதனம் Today - Breaking & Trending Today

Austin startup Everlywell adds HealthQuest Capital as investor

Austin startup Everlywell adds HealthQuest Capital as investor
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

Garheng Kong , Healthquest Capital , Ginkgo Bioworks , Intrivo Diagnostics , ஹெல்த்‌க்வெஸ்ட் மூலதனம் ,

Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M


Health tech giant Hillrom to acquire Seattle startup Bardy Diagnostics for $375M
January 19, 2021 at 10:31 am
Dr. Gust Bardy, founder of Bardy Diagnostics. (Bardy Photo)
Hillrom, a publicly-traded medical device and digital health company based in Chicago, will pay $375 million to acquire Seattle startup Bardy Diagnostics.
Founded in 2013, Bardy set out to change the way medical professionals monitor heart conditions with a non-invasive cardiac monitor patch that helps detect arrhythmia. The Carnation Ambulatory Monitor, or CAM for short, is designed to be worn comfortably for approximately a week, with the goal of improving patient compliance. It uses a unique circuit design and algorithms to process P-wave recording. Bardy claims that its device captures clearer and more accurate heart rhythms than competing electrocardiography (ECG) monitors. ....

United States , John Groetelaars , Sv Health Investors , Boston Scientific , Health Enterprise Partners , University Of Washington , Seattle Institute For Cardiac Research , Cameron Health , River Cities Capital Fund , Rex Health Ventures , Gust Bardy , Bardy Photo , Carnation Ambulatory Monitor , New Providence , Advancing Connected Care , River Cities Capital , Healthquest Capital , Aperture Venture Partners , Aphelion Capital , Lumira Ventures , Seattle Institute , ஒன்றுபட்டது மாநிலங்களில் , ஸ்வ் ஆரோக்கியம் முதலீட்டாளர்கள் , போஸ்டன் அறிவியல் , ஆரோக்கியம் நிறுவன கூட்டாளர்கள் , பல்கலைக்கழகம் ஆஃப் வாஷிங்டன் ,

Everlywell raises $75M from HealthQuest Capital following its recent $175M Series D round – TechCrunch


Everlywell raises $75M from HealthQuest Capital following its recent $175M Series D round
At-home health testing kit startup Everlywell has raised $75 million, following the close of the $175 million Series D it announced in December. The new funding comes from HealthQuest Capital, and sees the fund’s founder and managing partner Dr. Garheng Kong join the company’s board of directors. Everlywell will use proceeds of this financing to provide liquidity to existing investors, so the startup’s $1.3 billion valuation from December still holds.
HealthQuest Capital’s investment portfolio has a heavy focus on commercialization of diagnostics businesses, and the company’s parent obviously has a board network of partners including hospitals and healthcare payers, both of which are going to be very strategically useful to Everlywell as it looks to scale its business on the enterprise side. ....

Garheng Kong , Healthquest Capital , Cquest Capital , Julia Cheek , ஹெல்த்‌க்வெஸ்ட் மூலதனம் , தேடலை மூலதனம் , ஜூலியா கன்னம் ,

Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance


Venus Concept Reports Preliminary Revenue Results for Fourth Quarter 2020; Introduces Fiscal Year 2021 Revenue Guidance
January 14, 2021 06:30 ET
| Source:
Venus Concept Inc.
Venus Concept Inc.
San Jose, California, UNITED STATES
TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudited revenue results for the three months ended December 31, 2020 and introduced revenue guidance expectations for the twelve months ended December 31, 2021.
Management Commentary:
“We continued to see improvements in the operating environment in our key markets in the fourth quarter as evidenced by the 22% to 27% growth quarter-over-quarter implied by our preliminary revenue range,” said Domenic Serafino, Chief Executive Officer of Venus Concept. “The improvement in growth ....

United States , Venus Fiore , Domenic Serafino , Venus Viva , Venus Epileve , Exchange Commission , Venus Concept Inc , Securities Exchange , Chief Executive Officer , Venus Bliss , Fourth Quarter , Fiscal Year , North America , Venus Versa , Venus Legacy , Venus Velocity , Venus Freeze Plus , Venus Heal , Venus Glow , Robotic Hair Restoration , Essex Woodlands , Healthquest Capital , Longitude Capital Management , Aperture Venture , Securities Act , Securities Exchange Act ,